NCT03876899

Brief Summary

Breastfeeding related mastalgia is a common post-partum complaint. We propose a double-blind, randomized, placebo-controlled trial that investigates the use of Evening Primrose Oil in the treatment of breastfeeding related mastalgia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

March 15, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

March 15, 2019

Status Verified

March 1, 2019

Enrollment Period

6 months

First QC Date

March 14, 2019

Last Update Submit

March 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Breastfeeding Related Mastalgia

    Visual Pain Score

    7 days

Secondary Outcomes (1)

  • Adverse events

    7 days

Study Arms (2)

Evening Primrose Oil

ACTIVE COMPARATOR
Dietary Supplement: Evening Primrose Oil

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Placebo

Interventions

Evening Primrose OilDIETARY_SUPPLEMENT

botanical oil derivative from the seeds of Evening Primrose (Oenothera biennis),1,300 milligrams t.i.d.

Evening Primrose Oil
PlaceboDIETARY_SUPPLEMENT

Pill

Placebo

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • currently breastfeeding
  • recent delivery within the trailing 60 days

You may not qualify if:

  • history of seizure disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Feeding

Interventions

evening primrose oil

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Central Study Contacts

Richard Vigh, MD

CONTACT

James Anasti, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blind, randomized, placebo-controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2019

First Posted

March 15, 2019

Study Start

March 15, 2019

Primary Completion

August 30, 2019

Study Completion

September 30, 2019

Last Updated

March 15, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share